Wolverine Trading
RVMD icon

Wolverine Trading’s Revolution Medicines RVMD Stock Holding History

Wolverine Trading’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.23M Buy
26,800
+2,500
+10% +$97.9K ﹤0.01% 2682
2025
Q2 		$897K Buy
24,300
+17,900
+280% +$688K ﹤0.01% 2418
2025
Q1 		$239K Sell
6,400
-8,200
-56% -$333K ﹤0.01% 3769
2024
Q4 		$630K Buy
14,600
+9,200
+170% +$464K ﹤0.01% 3128
2024
Q3 		$239K Sell
5,400
-13,400
-71% -$583K ﹤0.01% 3875
2024
Q2 		$730K Buy
+18,800
New +$703K ﹤0.01% 2484

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wolverine Trading's RVMD Position: Q3 2025 in Review

Wolverine Trading increased its Revolution Medicines (RVMD) stake by 35% in Q3 2025, buying an estimated $166K and bringing the position to 16,241 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

Wolverine Trading first reported a position in RVMD in Q4 2023 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Wolverine Trading held 16,241 shares of Revolution Medicines worth $748K as of Q3 2025.
  • Wolverine Trading bought 4,242 Revolution Medicines shares in Q3 2025, an estimated $166K.
  • Revolution Medicines made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3221 holding.
  • Wolverine Trading first reported a position in Revolution Medicines in Q4 2023 and has held it in 6 quarters since.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.